Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ozurdex for macular edema associated with retinitis pigmentosa
KCT0002497Phase 4Completed
- Sponsor
- Allergan
- Start
- May 2014
- Modality
- Small Molecules, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 4 trial of ozurdex in cystoid macular edema (CME), retinitis pigmentosa (RP), sponsored by Allergan. Started May 2014; status: completed.
02
Drugs
ozurdex
03
Conditions
cystoid macular edema (CME)retinitis pigmentosa (RP)
Beyond the preview
Go deeper on KCT0002497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0002497.